Adverse HBOC-Endothelial Dysfunction Synergism: A Possible Contributor to Adverse Clinical Outcomes?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6220|9|3|194-203

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.9, Iss.3, 2012-09, pp. : 194-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adverse Effects of ACE Inhibitors in Patients with Chronic Heart Failure and/or Ventricular Dysfunction: Meta-Analysis of Randomised Clinical Trials

By Agustí A.   Bonet S.   Arnau J.M.   Vidal X.   Laporte J-R.  

Drug Safety, Vol. 26, Iss. 12, 2003-01 ,pp. : 895-908

Adis International

Access to resources Recommend Favorite

ART not associated with major adverse maternal outcomes

By  

Inpharma, Vol. 1, Iss. 1489, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

The Role of the Clinical Pharmacologist in the Management of Adverse Drug Reactions

By Moore N.  

Drug Safety, Vol. 24, Iss. 1, 2001-01 ,pp. : 1-7

Adis International

Access to resources Recommend Favorite

Adverse Effects of Observational Studies When Examining Adverse Outcomes of Drugs: Case-Control Studies with Low Prevalence of Exposure

By Austin P.C.  

Drug Safety, Vol. 25, Iss. 9, 2002-01 ,pp. : 677-687

Adis International

Access to resources Recommend Favorite

TZDs linked to adverse CV outcomes in older DM patients

By  

Inpharma, Vol. 1, Iss. 1619, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite